🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
2 different formulations and 4 different single doses of tafamidis will be ...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2018-09-28
Trial ID
NCT03662191
Treatments Being Tested
Each subject will be given tafamidis. After swallowing a single tafamidis c...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2014-10
Trial ID
NCT02217813
This was a single center, prospective cohort study that is evaluating the a...
Status
Completed
Location
Columbia University Irving Medical Center
Start Date
2022-07-08
Trial ID
NCT05635045
Treatments Being Tested
This study in healthy male and female volunteers will investigate the safet...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2012-07
Trial ID
NCT01655511
Introduction: Transthyretin cardiac amyloidosis (ATTR) is an important caus...
Status
Recruiting
Location
CHU de Caen
Start Date
2020-10-08
Trial ID
NCT04535349
Treatments Being Tested
3 different formulations and doses of tafamidis will be compared. Subjects ...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2016-04
Trial ID
NCT02697864
Treatments Being Tested
Cardiac transthyretin amyloidosis (ATTR), caused by ventricular depositions...
Status
Recruiting
Location
USB
Start Date
2001-02-22
Trial ID
NCT04776824
The purpose of this clinical trial is to compare the amount of tafamidis in...
Status
Completed
Location
Pfizer Clinical Research Unit - Brussels
Start Date
2022-08-29
Trial ID
NCT05482308
Treatments Being Tested
This study is designed to determine the long-term safety and tolerability o...
Status
Completed
Location
FLENI Departamento de Hepatología y Transplante de Organos
Start Date
2008-07
Trial ID
NCT00791492
Treatments Being Tested
Transthyretin amyloid cardiomyopathy (ATTR-CM), is a heart muscle disease t...
Status
Recruiting
Location
University Medical Centre Groningen
Start Date
2021-08-25
Trial ID
NCT05776212
Treatments Being Tested